ev3
Plymouth
About ev3
ev3 is a global leader and best-in-class technology provider for specialists treating a wide range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a comprehensive portfolio of treatment options, including the primary interventional technologies used today - peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, flow diversion, thrombectomy catheters and occlusion balloons.. With a legacy in technology development and innovation, ev3 is helping endovascular specialists around the world perform more efficiently, effectively and predictably. ev3. Your endovascular company.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 1,001 – 5,000
- Total funding: $34.6M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jun 2009)
- Ticker: nasdaq:EVVV
- Website: ev3.net
- Phone: +1 7633987797
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/ev3-2631444 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.